Citation 11860

NAGAO,T: ABE,F: KINJO,J: OKABE,H:. (2002). ANTIPROLIFERATIVE CONSTITUENTS IN PLANTS. 10. FLAVONES FROM THE LEAVES OF LANTANA MONTEVIDENSIS BRIQ. AND CONSIDERATION OF STRUCTURE-ACTIVITY RELATIONSHIP.. 25(7)

Citation Details

Title	ANTIPROLIFERATIVE CONSTITUENTS IN PLANTS. 10. FLAVONES FROM THE LEAVES OF LANTANA MONTEVIDENSIS BRIQ. AND CONSIDERATION OF STRUCTURE-ACTIVITY RELATIONSHIP.
Authors	NAGAO,T: ABE,F: KINJO,J: OKABE,H:
Year	2002
Volume	25
Issue	7

Summary

Year: 2002

Journal: Unknown

Organisms and Their Experiments (2)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE,6-METHOXY:	ACTIVE
2	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE,6-METHOXY:	EQUIVOCAL
3	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE,6-METHOXY:	EQUIVOCAL
4	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE,7-METHOXY:	WEAK ACTIVITY
5	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE,7-METHOXY:	EQUIVOCAL
6	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE,7-METHOXY:	EQUIVOCAL
7	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CHRYSIN	ACTIVE
8	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CHRYSIN	WEAK ACTIVITY
9	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CHRYSIN	WEAK ACTIVITY
10	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	LUTEOLIN	ACTIVE
11	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	LUTEOLIN	WEAK ACTIVITY
12	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	LUTEOLIN	WEAK ACTIVITY
13	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BAICALEIN	WEAK ACTIVITY
14	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BAICALEIN	WEAK ACTIVITY
15	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BAICALEIN	WEAK ACTIVITY
16	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	LUTEOLIN,6-HYDROXY:	WEAK ACTIVITY
17	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	LUTEOLIN,6-HYDROXY:	WEAK ACTIVITY
18	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	LUTEOLIN,6-HYDROXY:	WEAK ACTIVITY
19	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PECTOLINARIGENIN	ACTIVE
20	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PECTOLINARIGENIN	EQUIVOCAL
21	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PECTOLINARIGENIN	WEAK ACTIVITY
22	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CENTAUREIDIN,DEMETHOXY:	ACTIVE
23	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CENTAUREIDIN,DEMETHOXY:	WEAK ACTIVITY
24	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CENTAUREIDIN,DEMETHOXY:	WEAK ACTIVITY

Lantana montevidensis (VERBENACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
2	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
3	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
4	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	CIRSILINEOL	None
5	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CIRSILINEOL	EQUIVOCAL
6	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CIRSILINEOL	WEAK ACTIVITY
7	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CIRSILINEOL	WEAK ACTIVITY
8	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	EUPATORIN	None
9	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	EUPATORIN	WEAK ACTIVITY
10	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	EUPATORIN	WEAK ACTIVITY
11	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	EUPATORIN	WEAK ACTIVITY
12	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	FLAVONE,4'-5-DIHYDROXY-3'-5'-6-7-TETRAMETHOXY:	None
13	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE,4'-5-DIHYDROXY-3'-5'-6-7-TETRAMETHOXY:	INACTIVE
14	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE,4'-5-DIHYDROXY-3'-5'-6-7-TETRAMETHOXY:	INACTIVE
15	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE,4'-5-DIHYDROXY-3'-5'-6-7-TETRAMETHOXY:	EQUIVOCAL
16	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	FLAVONE,5-6-DIHYDROXY-3'-4'-7-TRIMETHOXY:	None
17	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE,5-6-DIHYDROXY-3'-4'-7-TRIMETHOXY:	WEAK ACTIVITY
18	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE,5-6-DIHYDROXY-3'-4'-7-TRIMETHOXY:	WEAK ACTIVITY
19	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE,5-6-DIHYDROXY-3'-4'-7-TRIMETHOXY:	WEAK ACTIVITY
20	Not specified	UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATA	FLAVONE,4'-5-6-TRIHYDROXY-3'-5'-7-TRIMETHOXY:	None
21	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE,4'-5-6-TRIHYDROXY-3'-5'-7-TRIMETHOXY:	WEAK ACTIVITY
22	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE,4'-5-6-TRIHYDROXY-3'-5'-7-TRIMETHOXY:	WEAK ACTIVITY
23	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE,4'-5-6-TRIHYDROXY-3'-5'-7-TRIMETHOXY:	WEAK ACTIVITY
24	Not specified	UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATA	FLAVONE,3'-5-6-TRIHYDROXY-4'-7-DIMETHOXY:	None
25	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE,3'-5-6-TRIHYDROXY-4'-7-DIMETHOXY:	WEAK ACTIVITY
26	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE,3'-5-6-TRIHYDROXY-4'-7-DIMETHOXY:	WEAK ACTIVITY
27	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE,3'-5-6-TRIHYDROXY-4'-7-DIMETHOXY:	WEAK ACTIVITY
28	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	FLAVONE,3'-4'-5-TRIHYDROXY-5'-6-7-TRIMETHOXY:	None
29	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE,3'-4'-5-TRIHYDROXY-5'-6-7-TRIMETHOXY:	WEAK ACTIVITY
30	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE,3'-4'-5-TRIHYDROXY-5'-6-7-TRIMETHOXY:	WEAK ACTIVITY
31	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE,3'-4'-5-TRIHYDROXY-5'-6-7-TRIMETHOXY:	WEAK ACTIVITY
32	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	CIRSILIOL	None
33	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CIRSILIOL	WEAK ACTIVITY
34	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CIRSILIOL	WEAK ACTIVITY
35	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CIRSILIOL	ACTIVE
36	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	HISPIDULIN	None
37	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	HISPIDULIN	WEAK ACTIVITY
38	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	HISPIDULIN	WEAK ACTIVITY
39	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	HISPIDULIN	WEAK ACTIVITY
40	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	APIGENIN	None
41	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	APIGENIN	WEAK ACTIVITY
42	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	APIGENIN	WEAK ACTIVITY
43	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	APIGENIN	WEAK ACTIVITY
44	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	EUPAFOLIN	None
45	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	EUPAFOLIN	ACTIVE
46	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	EUPAFOLIN	WEAK ACTIVITY
47	ANTIPROLIFERATION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	EUPAFOLIN	WEAK ACTIVITY